This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cellana Announces Key Appointments And Promotions

SAN DIEGO and KAILUA-KONA, Hawaii, Oct. 1, 2013 /PRNewswire/ -- Cellana, a leading developer of algae-based feedstocks for biofuels, animal feed/food and Omega-3 nutritional oils, announced today that Valerie Harmon has been appointed as Cellana's senior director of Research and Development (Kona), Xuemei Bai, Ph.D., has been promoted to senior director of Research and Development ( San Diego) and Selena Ellis-Vizcarra has been promoted to senior director of Corporate Development.  

Harmon has over 25 years of experience in industrial-scale and commercial-scale algae production and will assume primary responsibility for the large-scale production of algae biomass in Cellana's Kona Demonstration Facility. Prior to joining Cellana, she most recently served as director of Cultivation, Environment and Safety Systems with Aurora Algae. Before Aurora, Harmon served in multiple roles with Cyanotech Corporation, a world leader in the commercial production of algae-based astaxanthin and spirulina for nutraceutical applications, including as director of Cultivation and director of Business Development and Animal Feeds and technical sales manager. She is a co-author on numerous toxicology, oyster aquaculture and algae-related publications. Harmon has a B.S. in biology from Davidson College and a master's degree in agriculture, aquaculture and business strategy from Oregon State University.

"We are excited to welcome Valerie to the Cellana family. Valerie brings significant expertise and knowledge in algae development and production," said Michael J. Kamdar, Cellana's president. "We look forward to Valerie leading our research and development efforts at our Kona Demonstration Facility as we continue to grow our organization towards commercial production."

Since 2008, Dr. Bai has served as a key member of Cellana's R&D department with increasing levels of responsibility and is Cellana's principal investigator for multiple grant programs funded by the U.S. Department of Energy (DOE) and/or Department of Agriculture (USDA). She currently leads Cellana's efforts in algal strain development for ReNew™ Omega-3, ReNew™ Fuel and ReNew™ Feed products in both of Cellana's ALDUO™ mid-scale screening and cultivation system as well as the ALDUO™ large-scale cultivation system at the Kona Demonstration Facility. In addition to her focus on upstream algal cultivation technology for bioproducts development, Dr. Bai also works with downstream partners on algae biomass processing, including lipid extraction, purification of Omega-3s and biofuels refining. Dr. Bai has a B.S. in fisheries from Dalian Fisheries University in Dalian, China, a master's degree in aquatic biology from Huazhong Agricultural University in Wuhan, China and a Ph.D. in marine science from the University of Southern Mississippi, Stennis Space Center, where her Ph.D. research was focused on photosynthetic carbon flux direction ( i.e., oils, sugars and proteins) under different environmental regimes and separation techniques for photosynthetic end products of algae.

"Xuemei has done an outstanding job of leading our research and development team," said Kamdar.  "As part of her promotion, Xuemei will relocate to San Diego as the first step in establishing a research and development capability in Southern California and exploring a potential Cellana commercial facility on the mainland U.S.  This is a very significant step in Cellana's development."

Ellis-Vizcarra has served as a key member of Cellana's Corporate Development department since 2011. Under her leadership, Cellana has obtained, negotiated and executed more than four multi-million-dollar federally funded programs during her tenure at Cellana, amounting to over $5 million in revenue for Cellana. Prior to joining Cellana, Ellis-Vizcarra was with Verenium (formerly Diversa) Corporation, holding a variety of increasingly responsible positions in the business development, finance/accounting, intellectual property and corporate development departments, with her final position being contracts manager. Ellis-Vizcarra has been in the biotechnology sector as a project manager often for government-funded projects and for cross-functional teams for over 20 years, with responsibility for over $150 million in cumulative funding.  Ellis-Vizcarra has a B.A. in economics and a master of business administration, both from San Diego State University.

"Selena has done an outstanding job of obtaining and managing our federal programs from a corporate and administrative perspective and has been a key team member on our current Series A corporate financing round," said Martin A. Sabarsky, Cellana's chief executive officer. "She has provided excellent leadership with our internal and external grant coordinators and has been an invaluable interface between departments within Cellana as well as with external partners."    

About Cellana

Cellana, a leading developer of algae-based bioproducts, uses the most productive plants on earth — marine microalgae — to photosynthetically produce its ReNew™ line of Omega-3 EPA and DHA oils, animal feed/food, and biofuel feedstocks.  Cellana's patented ALDUO™ system enables economic, sustainable and consistent production of photosynthetic, non-GMO algae at industrial scale. Cellana intends to construct and operate commercial facilities to produce these products as integrated algae-based biorefineries. To date, over $100 million has been invested in developing Cellana's algae strains, patented and proprietary production technologies, and its Kona Demonstration Facility. Further information is available at:

Cellana®, the Cellana logo, ALDUO, ReNew, and other trademarks or service names are trademarks of Cellana, Inc

SOURCE Cellana

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs